Try our Advanced Search for more refined results
ELI LILLY AND COMPANY et al v. XAVIER BECERRA et al
Case Number:
1:24-cv-03220
Court:
Nature of Suit:
Administrative Procedure Act/Review or Appeal of Agency Decision
Judge:
Firms
- Bass Berry
- Frier Levitt
- Hogan Lovells
- Kirkland & Ellis
- Latham & Watkins
- Nelson Mullins
- Zuckerman Spaeder
Companies
- American Hospital Association
- America's Essential Hospitals
- Arkansas Hospital Association
- Association of American Medical Colleges
- Biotechnology Innovation Organization
- California Hospital Association
- Eli Lilly & Co.
- Florida Hospital Association Inc.
- Genesis HealthCare Corp.
- Georgia Hospital Association
- Greater New York Hospital Association
- Healthcare Association of Hawaii
- Indiana Hospital Association
- Iowa Hospital Association
- Kentucky Hospital Association
- Louisiana Hospital Association
- Michigan Health & Hospital Association
- Mississippi Hospital Association
- Missouri Hospital Association
- New Jersey Hospital Association
- Pharmaceutical Research & Manufacturers of America
- Texas Hospital Association
- The Hospital and Healthsystem Association of Pennsylvania
- UMass Memorial Health Care Inc.
- Washington Legal Foundation
- West Virginia Hospital Association
- Wisconsin Hospital Association
Government Agencies
Sectors & Industries:
-
March 18, 2025
Texas Abortion Charges, HHS Rehirings And FTC Deal Warning
The Trump administration is seeking an emergency halt of a Maryland federal court order that led the Department of Health and Human Services to delay the terminations of almost 3,000 probationary employees, arguing it has burdened HHS and over a dozen other federal agencies behind the mass firings. Here, Law360 Healthcare Authority looks at these and other significant cases and decisions that shaped the healthcare industry over the last week.
-
March 18, 2025
HHS Seeks Early Win Over Lilly, Novartis, BMS In Rebate Row
The U.S. Department of Health and Human Services urged a D.C. federal judge Monday to grant it an early win against behemoth drugmakers' claims that it unlawfully blocked their plans to offer after-the-fact rebates, rather than up-front discounts, to safety-net hospitals via a decades-old federal drug pricing program.
-
February 18, 2025
340B Rebate Clash Triggers 5 Suits By Drugmakers
The federal agency overseeing the 340B drug pricing program faces five distinct legal challenges by drugmakers that say the agency illegally blocked their plans to offer rebates rather than upfront discounts to participating hospitals.
-
January 01, 2025
High-Stakes Healthcare Court Battles To Watch In 2025
With pivotal health law cases on the docket in 2025, attorneys will be watching how the incoming Trump administration proceeds in ongoing litigation over abortion care, the Affordable Care Act and the Medicare drug price negotiation program.
-
November 15, 2024
Eli Lilly Says HHS Ignores Drug Discount Double-Dipping
Eli Lilly & Co. claims the U.S. Department of Health and Human Services is unlawfully blocking its efforts to crack down on hospitals the company alleges are double-dipping on medication discounts that are meant to benefit low-income patients, according to a lawsuit filed in D.C. federal court.